• Cutting Edge Technology and Next Generation Bioprocessing Trends
  •  Special Focus on Antibodies and Vaccines for In-Depth, Specific Discussions
  •   Regional & International Case Studies from Top Pharma Companies

Productivity and Innovation Credit (PIC) Grant - IRAS (Singapore-registered businesses) 
Enjoy a 60% cash payout or 400% tax reduction when you attend any of IBC Asia’s conferences/courses in Singapore! Visit www.ibc-asia.com/pic today for more information!

‘’Biopharmaceuticals continue to be a growing, important class of pharmaceutical products on the market, and many of these products are produced using mammalian cell culture with total biopharmaceutical sales reaching nearly $130 billion, or approximately 13% of the total pharmaceutical market.’’ – BioProcess Technology, 2014

IBC Asia's BioProcess & Technology Summit provides a platform for industry leaders to overcome the most pressing challenges in bioprocess and manufacturing of biologics and bringing them to the market successfully.

This event will highlight the exciting developments in advanced bioprocessing techniques with a special focus on antibody and vaccines in the Asia-Pacific market, exploring best practices in manufacturing facilities and production, with regional and international case studies from top companies.

Bring back best practice insights and tools to implement in your company, to increase efficiency, productivity, ensure quality and accelerate their arrival to the market!

2015 Speakers Included

Pierre A. Morgan
Chief Executive Officer
AJ Biologics, Malaysia

Joe Zhou
CEO, Genor Biopharma & Vice President
Walvax Group, China
Alain Bernard
Vice President, Head of Global Technical Operation Business Excellence
UCB, Belgium
Christian Cater
Head, Operational Excellence
Novartis Pharmaceutical Manufacturing, Singapore

Anil Sood
Vice President and Site Head
Panacea Biotech, India

View all speakers »


2015 Key Conference Topics

Combined Sessions:

  • Regulatory Considerations for Efficient Approvals
  • Adapting to Single-use Systems & Maximizing Capacity in Existing Facilities
  • Process Tech Transfer to Multiproduct Facilities & cGMP Manufacturing
  • Flexible Facilities & Next Generation Bioprocessing
  • Futuristic Features of a Next-Generation Bioprocessing Plant
  • Effective Facility Design & Management Best Practices

Antibodies Track:

  • Advancements in Gene Expression & High Throughput Screening for Antibodies Development
  • Latest Technologies & Techniques for Improved Process Development
  • Best Platform Processes & CMC Solutions for mAb Production
  • Analytical Strategies for Increased Quality in Bioproduction
  • Improving Quality Processes- QbD, DoE, PAT
  • Overcoming Processing Issues in Early Biosimilar Development
  • Challenges in Fc Fusion Proteins Development
  • Downstream Processing & Purification
    • Robust Impurity Clearance Techniques
    • Tools to Prevent Protein Aggregation
    • Continuous Chromatography Trends
    • Predictive Downstream Scaled-Down Models

Vaccines Track:

  • Vaccine Manufacturing in SEA and beyond
  • Facilities Design for Vaccines Production
  • Vaccines Cold Chain Management
  • Halal Vaccines
  • Essential Media Optimization for Vaccine Development
  • Continuous Processing and Single-Use for Vaccines
  • Process Improvements in Vaccines Manufacturing
  • Improving Quality Processes in Vaccines Development
  • Purification & Downstream Processing Essentials

View full agenda »

Produced byPast SponsorPast ExhibitorPast Supporting Agency

Past Media Partners